Where DSIP fits and where it does not Because the evidence is weak, the appropriate role for DSIP in any clinical conversation is narrow
Peptide combination rationale: AREDS2 provides antioxidants and macular pigment
Analyzing a series of studies using differing amounts of B12 via injection, the IOM determined that 1.5 g of absorbed B12 per day was enough to normalize red blood cell parameters (hematocrit, red blood cell volume, and anemia) in the average patient with pernicious anemia
however, they exhibit limitations in terms of oral bioavailability and plasma half-life, and they are unable to completely prevent iron-mediated oxidative stress [73]
This synergy enhances its absorption and boosts its skin-clearing potential
Keeping the peptide in lyophilized form and reconstituting fresh solution when needed is the preferred approach